search: results update below
recently rated:
Rated by 4
2.0
$$$$$ New York, US East
top rated funds:
Rated by 16
4.0
$$$$$ Santa Barbara, CA, US West
Rated by 16
4.0
$$$$$ Menlo Park, US West
Rated by 43
3.9
$$$$$ Palo Alto, US West
Rated by 11
3.8
$$$$$ Luxembourg, Europe
Rated by 45
3.8
$$$$$ New York, US East
Rated by 107
3.8
$$$$$ Menlo Park, US West
Rated by 33
3.8
$$$$$ Menlo Park, US West
Rated by 32
3.8
$$$$$ Boston, US East
Rated by 64
3.7
$$$$$ San Francisco, US West
Rated by 23
3.7
$$$$$ Houston, US Central
Rated by 27
3.7
$$$$$ Palo Alto, US West
Rated by 11
3.7
$$$$$ Red Bank, US East
Rated by 13
3.7
$$$$$ San Francisco, US West
Rated by 11
3.6
$$$$$ Santa Fe, US West
Rated by 19
3.6
$$$$$ Menlo Park, US West
Rated by 64
3.6
$$$$$ Menlo Park, US West
Rated by 15
3.5
$$$$$ US West
Rated by 21
3.5
$$$$$ Munich, Europe
Rated by 12
3.5
$$$$$ London, Europe
Rated by 30
3.5
$$$$$ Santa Monica, US West
Rated by 28
3.4
$$$$$ San Francisco, US West
Rated by 49
3.4
$$$$$ Menlo Park, US West
Rated by 16
3.4
$$$$$ Menlo Park, US West
Rated by 10
3.4
$$$$$ London, Europe
Rated by 13
3.4
$$$$$ London, Europe
Rated by 16
3.4
$$$$$ Los Angeles, US West
Rated by 61
3.4
$$$$$ Menlo Park, US West
Rated by 17
3.4
$$$$$ Foster City, US West
Rated by 39
3.3
$$$$$ Waltham, US East
Rated by 28
3.3
$$$$$ New York, US East
Please take a moment and make a financial contribution to TheFunded. If we have helped you, help us with resources to further grow the both the site and our entrepreneur training program, The Founder Institute.
Simona Kicova
Partner Rating:
Un-rated
Partner Information:
Title: Ms.
Location: London, Europe
Firm Rating:
Un-rated
Firm Information:
Type: Large Private VC
PERSONAL SPECIALTY: Senior Client Administrator
FIRM DESCRIPTION: Our fund has been recently established and is currently seeking to complete its first major investment. AC Pharm is seeking to invest €10 -30 million in niche investment targets representing the highest growth potential in ready to market pharmaceutical technologies. It is hoped that the first round of significant capital allocations will be completed over the next 6 months.
We hope to work with smaller companies and entrepreneurial research facilities. Our aim is tohelp businesses to grow by providing financial resources at critical development phases. We act with integrity and respect for the people we deal with.
If you are seeking funding and would like to discuss this with us, please email us at investorrelations@ACPharm.com